Gastrointestinal therapeutics Market Research Reports

"...... nd entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Pentasa in a special period. This......"

"...... ry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were ......"

"...... factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Esomeprazole in a speci......"

"...... t players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, A......"

"...... in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oce......"

"...... forecast by Type and by Application for the period 2016-2027. Segment by Type - Proton Pump Inhibitors (PPIs) - Potassium-Competitive Acid Blockers (P-CAB) - Antacids - H2 Antagonists - Ulcer Protect......"

"...... erapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered - Global coverage Ulcerative Colitis Understandin......"

"...... to 2026. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also included such as United States, China, Japan, India, Korea, AS......"

"...... 2016 to 2026. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also included such as United States, China, Japan, India, Korea......"

"...... by AstraZeneca AB. Esomeprazole was approved in China in 2007. By 2020, in addition to AstraZeneca AB, there are more than 10 generic drug manufacturers in the Chinese Esomeprazole market, such as Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Jia......"